Avraham Amar

4.5k citations

24 papers · 3.6k indexed · 2 hit papers · h-index 14

Impact in

Hematology top 0.2%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
Transplantation top 1%
- Renal Transplantation Outcomes and Treatments

Papers in

Hematology 12
- Hematopoietic Stem Cell Transplantation 12
- Acute Myeloid Leukemia Research 3
Immunology 18
- Immune Cell Function and Interaction 12
- T-cell and B-cell Immunology 9
- Immunotherapy and Immune Responses 4

Co-authors: Chaim Brautbar Reuven Or Arnon Nagler Simcha Samuel Shimon Slavin Aliza Ackerstein Memet Aker Gàbor Varadi
Journals: Blood (3 papers)Fertility and Sterility (2 papers)Human Immunology (2 papers)Transplantation (2 papers)Journal of Pediatric Hematology/Oncology (1 paper)
Partner nations: Israel United States France

In The Last Decade

Avraham Amar

24 papers receiving 3.5k citations

Hit Papers

align trajectories log scale

Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases 1998 · 1.5k citations

Peers

Countries citing papers authored by Avraham Amar

Since Specialization

Citations

This map shows the geographic impact of Avraham Amar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avraham Amar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avraham Amar more than expected).

Fields of papers citing papers by Avraham Amar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Avraham Amar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avraham Amar. The network helps show where Avraham Amar may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Avraham Amar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Avraham Amar Line = papers co-authored together Avraham Amar links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Successful cell‐mediated cytokine‐activated immunotherapy for relapsed acute myeloid leukemia after hematopoietic stem cell transplantation American Journal of Hematology ·Benjamin Gesundheit, Michael Y. Shapira, Igor Resnick, Avraham Amar, Don Kristt, 岩崎真樹, S. Milanesi, Reuven Or	2008	19
2	Sparing Effect by Montelukast Treatment for Chronic Graft Versus Host Disease: A Pilot Study Transplantation ·Reuven Or, Benjamin Gesundheit, Igor Resnick, Menachem Bitan, Avraham Amar, Meytal Avgil, 大田英輔, Michael Y. Shapira	2007	35
3	Gaucher-like Cells in β-Thalassemia Patient After Bone Marrow Transplantation Journal of Pediatric Hematology/Oncology ·Benjamin Gesundheit, Reuven Or, Avraham Amar, Dvora Filon, Gail Amir	2006	1
4	Successful transplantation of haploidentically mismatched peripheral blood stem cells using CD133+-purified stem cells Experimental Hematology ·Menachem Bitan, Michael Y. Shapira, Igor Resnick, T. Lee, 町田二郎, Simcha Samuel, Aliza Ackerstein, Elad Sharon, A. G. Gutierrez-Cirlos, Avraham Amar, Eitan Fibach, Reuven Or, Shimon Slavin	2005	27
5	Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase Blood ·Reuven Or, Michael Y. Shapira, Igor Resnick, Avraham Amar, Aliza Ackerstein, Simcha Samuel, Memet Aker, Elizabeth Naparstek, Arnon Nagler, Shimon Slavin	2002	151
6	HLA Class II Susceptibility to Multiple Sclerosis Among Ashkenazi and Non-Ashkenazi Jews Archives of Neurology ·Oh Joong Kwon, Arnon Karni, Shoshana Israel, Chaim Brautbar, Avraham Amar, Zeev Meiner, Oded Abramsky, EVA TIEN	1999	63
7	Graft-Versus-Lymphoma Effect after Allogeneic Peripheral Blood Stem Cell Transplantation for Primary Central Nervous System Lymphoma Leukemia & lymphoma ·Gàbor Varadi, Reuven Or, Joseph Kapelushnik, Cynthia Carolina Mena Mena, Arnon Nagler, Aune Stavén-Grönberg, Avraham Amar, Mark Kirschbaum, Simcha Samuel, Shimon Slavin, Tali Siegal	1999	36
8	Minitransplants and cell-based therapies for malignant and nonmalignant disorders Current Opinion in Organ Transplantation ·Shimon Slavin, Arnon Nagler, Cynthia Carolina Mena Mena, Memet Aker, Gabriel Cividalli, Gàbor Varadi, Aliza Ackerstein, Simcha Samuel, Avraham Amar, Chaim Brautbar, Reuven Or	1999	5
9	Allogeneic Cell-Mediated and Cytokine-Activated Immunotherapy for Malignant Lymphoma at the Stage of Minimal Residual Disease After Autologous Stem Cell Transplantation Journal of Immunotherapy ·R. Or, Aliza Ackerstein, Arnon Nagler, Avraham Amar, J.W. Randen, Gàbor Varadi, Joseph Kapelushnik, Simcha Samuel, Thea Pugatsch, Chaim Brautbar, Shimon Slavin	1998	26
10	An association between clozapine-induced agranulocytosis in schizophrenics and HLA-DQB10201 The International Journal of Neuropsychopharmacology* ·Avraham Amar, Ronnen H. Segman, Xiuqing Guo, E Trandafiresco, Marlen Higuera Rojas, Bernard Lerer, Chaim Brautbar	1998	34
11	Allogeneic cell-mediated immunotherapy for breast cancer after autologous stem cell transplantation: a clinical pilot study. PubMed ·Reuven Or, Aliza Ackerstein, Arnon Nagler, Joseph Kapelushnik, Elizabeth Naparstek, Simcha Samuel, Avraham Amar, Yimai Zhang, Shimon Slavin	1998	31
12	Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases Blood ·Shimon Slavin, Arnon Nagler, E Naparstek, Ekram Hossain Khan, Memet Aker, Gabriel Cividalli, Gàbor Varadi, Mark Kirschbaum, Aliza Ackerstein, Simcha Samuel, Avraham Amar, Chaim Brautbar, Ofira Ben‐Tal, A Eldor, Reuven Or Hit paper breakdown →	1998	1467
13	Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases Blood ·Shimon Slavin, Arnon Nagler, E Naparstek, Ekram Hossain Khan, Memet Aker, Gabriel Cividalli, Gàbor Varadi, Mark Kirschbaum, Aliza Ackerstein, Simcha Samuel, Avraham Amar, Chaim Brautbar, Ofira Ben‐Tal, A Eldor, Reuven Or Hit paper breakdown →	1998	1606
14	Predominant 45,X,-Y karyotype in donor cells after allogeneic BMT: Cytogenetic and molecular analysis Cancer Genetics and Cytogenetics ·Dvorah Abeliovich, Giovanni Di Stefano, Arnon Nagler, P Ramezanlou, Susana Ben‐Neriah, Avraham Amar, Reuven Or	1996	12
15	HLA class II analysis in Jewish Israeli narcoleptic patients Human Immunology ·Oh Joong Kwon, Nir Peled, Keren Miller, Antonio Grasso, Ron Peled, Peretz Lavie, Chaim Brautbar, Avraham Amar	1995	6
16	Two new DR52‐associated alleles, DRB11111 and 1312, identified by PCR/SSOP and confirmed by DNA sequencing Tissue Antigens ·Anajane G. Smith, Marlen Higuera Rojas, Fatoş BOYRAZ, Avraham Amar, John A. Hansen, Chaim Brautbar	1994	10
17	SPECIFIC ALLELIC VARIATION AMONG LINKED HLA CLASS II GENES Transplantation ·Avraham Amar, Susan L. Holbeck, Gerald T. Nepom	1987	12
18	HLA‐DQ heterogeneity among HLA‐DRw11(5) haplotypes Tissue Antigens ·Avraham Amar, Eric Mickelson, John A. Hansen, Gerald T. Nepom	1986	1
19	Maternal-paternal histocompatibility: lack of association with habitual abortions Fertility and Sterility ·Jorge R. Oksenberg, Iu. S. Sigov, Avraham Amar, Chaim Brautbar	1984	40
20	HLA‐DR2 and DR4 further defined by two new HLA‐D specificities (HTC) derived from Israeli Jewish donors: comparative study in Caucasian, Korean, Eskimo and Israeli populations Tissue Antigens ·Eric Mickelson, Chaim Brautbar, Brenda Nisperos, Nadine Cohen, Avraham Amar, Se‐Jong Kim, Anne P. Lanier, John A. Hansen	1984	13

About Avraham Amar

Avraham Amar is a scholar working on Hematology, Immunology, Biological Psychiatry, Radiology, Nuclear Medicine and Imaging and Immunology and Allergy, having authored 24 papers that have together received 3.6k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (12 papers), Hematopoietic Stem Cell Transplantation (12 papers), T-cell and B-cell Immunology (9 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Immunotherapy and Immune Responses (4 papers), Acute Myeloid Leukemia Research (3 papers), CAR-T cell therapy research (3 papers) and Acute Lymphoblastic Leukemia research (3 papers). The work is most often cited by research in Hematology (3.1k citations), Transplantation (269 citations), Immunology (1.4k citations), Genetics (612 citations) and Oncology (946 citations). Avraham Amar has collaborated with scholars based in Israel, United States and France. Frequent co-authors include Chaim Brautbar, Reuven Or, Arnon Nagler, Simcha Samuel, Shimon Slavin, Aliza Ackerstein, Memet Aker, Gàbor Varadi, Mark Kirschbaum and Gabriel Cividalli. Their work appears in journals such as Blood, Fertility and Sterility, Human Immunology, Transplantation and Journal of Pediatric Hematology/Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact